SARS-COV-2. SARS-associated coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Both genders Aged between 18-80 years Mild, moderate or severe infection COVID-19 positive on the basis of symptoms, physical test and lab test
Exclusion criteria
Exclusion criteria: Any tumor or malignancy Recent surgery Patient on invasive / non-invasive ventilator (critical) Taking any other medicine parallel to PAK-20, Oniater and Hing for treatment of COVID-19. Taking any immunosuppressant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: Before intervention and (1,3,5) odd days after intervention. Method of measurement: Thermometer.;Cough. Timepoint: Before intervention and (1,3,5,7,9,11) odd days after intervention. Method of measurement: Cough Scale.;Sore Throat. Timepoint: Before intervention and (1,3,5,7,9,11) odd days after intervention. Method of measurement: Sore Throat Scale.;Shortness of Breath. Timepoint: Before intervention and (1,3,5,7,9,11) odd days after intervention. Method of measurement: Borg Scale of Short of Breath.;Muscle Pain. Timepoint: Before intervention and (1,3,5,7,9,11) odd days after intervention. Method of measurement: Numeric pain rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| PCR-RT for COVID-19. Timepoint: Before intervention and 14th day after intervention. Method of measurement: PCR-RT Lab test.;Chest X-ray. Timepoint: Before intervention and on 14th day after intervention. Method of measurement: Radiological X-ray findings.;10 Second Breath Hold Test. Timepoint: Before intervention and on 14th day after intervention. Method of measurement: Physical 10 Second breath Hold. | — |
Countries
Pakistan
Contacts
Knowledge Research and Innovation Center, Pakistan (KRIC)